This cookie notice provides information about the types of cookies Bird & Bird uses and why we use them. To learn about the personal data we process in connection with twobirds.com and our other websites, and your data protection rights, please read our Privacy Notice.
Cookies are small data files that contain a string of characters. Cookies help us to improve our site and to deliver a better and more personalised service, for instance by storing information about your preferences and allowing us to recognise you when you return to our websites.
• Strictly Necessary Cookies: These cookies are essential in order to enable you to move around our websites and use features, such as accessing secure areas of the site or remembering language choices. Without these cookies, we would not be able to provide you with services like enabling appropriate content based on your type of device.
• Analytics Cookies: These cookies allow us to see if our websites are working well – for instance we can see which pages visitors go to most often, and if they get error messages.
• E-Marketing Cookies (Vuture): We use Vuture to send out marketing communications via email. If you click through from one of our emails to our websites, we use additional cookies to connect your e-marketing journey with your website journey. This is to help us to provide you with relevant content across our digital marketing channels.
Our analytic cookies expire 13 after months.
We ask you for your consent to use analytics cookies when you visit our websites. If you want to change your mind about this, you can do this by vising our consent management platform here.
Last Updated: 05 June 2020
The main article of our Competition & EU newsletter dives into the new ex ante regulatory regime that may soon appl… https://t.co/S222gMFBmz
RT @twobirdsmedia: Just launched: our Sports Group’s new microsite ‘Sports Law+’ which gives a detailed summary of the core ways in which o…
RT @twobirdsIP: Our latest podcast with Managing IP - @SallyShorthose and James Baillieu join Henry Hadad of Bristol Myers Squibb to discus…